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Background: Obesity is characterized by chronic inflammation, immune dysregulation, and alter-
ation of gene expression, associated with type 2 diabetes mellitus and cardiovascular disease. The
degree to which these changes occur in childhood obesity is not fully defined.
Aims and Methods: The aim was to investigate the effect of childhood obesity on immune cell
frequency,macrophage activation, cytokineproduction, and specific regulators ofmetabolic gene
expression. Profilingwas performed on peripheral blood from 29 obese and 20 nonobese children
using real-time PCR, ELISA, and flow cytometry.
Results: Fastingglucosewas similar inbothgroups, but therewas ahigher degreeof insulin resistance
inobese subjects (homeostasismodel of assessment for insulin resistance, 4.8 vs 0.84;P .001). Soluble
CD163, amarker ofmacrophage polarization to a proinflammatory profile,was elevated in the obese
comparedtononobesechildren (135vs105ng/mL;P .03). InvariantnaturalkillerT cellswere reduced
in the obese children (CD3 T cells, 0.31 vs 0.53%; P  .001). Cytokine profiling revealed significantly
elevated TNF- (6.7 vs 5.1 pg/mL; P  .01) and leptin (1186 vs 432 pg/mL; P  .001) and reduced
adiponectin (884 vs 1321 pg/mL; P  .001) in obese compared to nonobese children. Stimulation of
peripheral bloodmononuclear cells fromobese children resulted inhigher levels of IL-1 (2100 vs 1500
pg/mL; P  .018). There was a 4-fold increase in expression of microRNA33a (P  .001) and a 3-fold
increase in microRNA33b (P .017) in obese children.
Conclusion: Childhood obesity is associatedwith changes in immune cell frequency, inflammatory
environment, and regulation of metabolic gene expression. These changes have been causally
linked to the onset of metabolic disease in adulthood and suggest the future trajectory of obese
children to the development of type 2 diabetes mellitus and premature cardiovascular disease.
(J Clin Endocrinol Metab 99: E474–E478, 2014)
Obesity is associated with the development of seriousmetabolic comorbidities, including premature car-
diovascular disease and type 2 diabetes mellitus (T2DM).
The impact of weight on the immune andmetabolic sys-
temsisnowconsideredtobeadynamicbidirectionalprocess.
Immune system alterations in adult obesity are well de-
scribed, but the impact of childhood obesity on immune sta-
tus has been less well studied and is the focus of this work.
Inflammation underpins many obesity-related comor-
bidities. Proinflammatory cytokines are overexpressed in
adultobesity andare linked to themetabolic syndrome (1).
Similar proinflammatory profiles have been described in
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children, with reports of elevated C-reactive protein in
obese children as young as 3 years (2–4). Inflammatory
parameters such as IL-6, IL-8, IFN-, TNF-, monocyte
chemoattractant protein-1, and activated monocyte sub-
sets have been noted to be elevated, and the anti-inflam-
matory adipokine, adiponectin, was reduced in obese
compared to normal-weight children (4–7).
Macrophages play a distinct role in obesity-induced in-
sulin resistance and are major contributors to adipose tissue
inflammation (8). In healthy subjects, macrophages are reg-
ulatory M2 cells producing the anti-inflammatory cytokine
IL-10. In obesity, macrophages are polarized to the M1 in-
flammatory phenotype, producing the proinflammatory cy-
tokine IL-1.Asmacrophagesbecomeproinflammatory, re-
moval of the haptoglobin-hemoglobin receptor CD163
becomes up-regulated and is measurable as soluble CD163
(sCD163). sCD163 is strongly associated with insulin resis-
tance independently of inflammatory parameters such as
TNF- (9).We recently identified a role for iNKTcells in the
regulation of weight and metabolism in adult obesity (10).
Depletion of iNKTcells in obesemice is associatedwith pro-
liferation of M1 adipose macrophages (10).
This network of adiposity, immune cell dysregulation,
and inflammation is interconnected with fatty acid metabo-
lism and insulin signaling. We chose to study three critical
gene regulators upstream from these metabolic pathways.
MicroRNAs (miRs) are small, noncodingRNAs thatmodify
post-transcriptional target gene expression and are strongly
associated with metabolic disease in murine models and
adult humans (11).MiR-33a andMiR-33b are expressed in
multiple tissues includingmacrophagesandtarget sterol-reg-
ulatory element binding protein, which regulates lipid and
cholesterolhomeostasis (12).MiR-107regulates insulin sen-
sitivity by targeting caveolae plasmamembrane proteins, re-
ducing insulin receptor numbers, and negatively affecting
downstream insulin signaling (13, 14). Increased miR-107
expressionhasbeendescribed in insulin-resistantobeseadult
populations.
This study investigates sCD163 levels, circulating
iNKTcell frequency, cytokine profile, andmiRexpression
in obese and nonobese children.
Subjects and Methods
Study cohorts
Ethical approval was granted by the Ethics Committee, Our
Lady’s Children’s Hospital, Dublin, Ireland. Parents of all pa-
tients gave written informed consent.
Forty-nine children (29 obese, 20 nonobese) aged 6–18 years
were recruited. Subjects were categorized as obese or nonobese
using International Obesity Taskforce Body Mass Index (BMI)
centile charts. BMI was calculated as weight (kilograms)/height
(meters)2. Insulin (picomoles/liter), glucose (millimoles/liter),
and cholesterol (millimoles/liter) levels were measured after a
12-hour fast. A clinical examination was performed in all par-
ticipants, and a detailed history encompassing past medical his-
tory, current health, number and severity of previous infections,
occurrence of recent infection, and use of anti-inflammatory
medications was completed. Children with an underlying hor-
mone deficiency, genetic disorder, inflammatory condition, or
occurrence of recent acute infection were excluded.
Serum and peripheral blood mononuclear cell
(PBMC) analysis
PBMCsampleswere isolatedbydensity centrifugation as pre-
viously described (10). Cells were cultured in triplicate for 24
hours in media alone, media with lipopolysaccharide (LPS) (10
g/mL), ormediawith phorbolmyristate acetate (10ng/mL) and
ionomycin (5 g/mL). Serums and cell supernatants were ana-
lyzed for cytokine, adipokine, and sCD163 levels by ELISA.
Flow cytometric analysis
PBMCs were stained for iNKT cells using BD monoclonal
antibodies (6B11/CD3, BDBiosciences), as previously described
(14). Cellswere analyzed using FlowJo software. Cellswere elec-
tronically gated (lymphogate) by their density and granularity
and interrogated for the markers of interest. Results are ex-
pressed as a percentage of total T cells and determined using flow
minus-1 (FMO controls).
Circulating miR analysis
Total RNA with conservation of small RNAs was extracted
from PBMCs using the miRNeasy kit (QIAGEN) according to
the manufacturer’s instructions. Reverse transcriptase-specific
primers for miR-33a, miR-33b, and miR-107 (Applied Biosys-
tems) were used for all miR reverse transcription. Individual
quantitative PCRs were carried out on the 7900HT Fast Real-
time System (Applied Biosystems, Life Technologies) usingmiR-
33a, miR-33b, and miR-107 Taqman miR probes. SnoU6 was
used for normalization miR expression studies. A relative fold
change in expressionof the target gene transcriptwasdetermined
using the comparative cycle threshold method (2CT).
Statistical analyses
All analyseswereperformedusingGraphPadPrism6 (Graph-
Pad Software, Inc). Results are expressed asmean SD. Groups
were compared using Student’s t test orMann-WhitneyU test as
appropriate. Parameter correlation was determined using Pear-
son correlation coefficients.P values are reportedwith statistical
significance set at  .05.
Results
Weight, BMI, and metabolic parameters
Characteristics of the study participants are detailed in
Table 1. Fasting glucose was similar in both groups, but
there was increased insulin resistance in the obese cohort.
Mean fasting cholesterol levels were elevated, and high-
density lipoprotein levelswere reduced in the obese cohort
compared to their nonobese counterparts (Table 1).
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sCD163 quantification
Higher levels of sCD163 were seen in the obese group
(142 vs 107 ng/mL; P  .03) (Figure 1A), and the level
correlated positively with increasing BMI (r  0.32; P 
.02) but not with fasting insulin (Figure 1, B and C).
Enumeration of iNKT cells
iNKT cell frequency was reduced within the obese co-
hort (0.32 vs 0.54%; P  .001) (Figure 1D). The change
in iNKT cells was inversely correlated with sCD163 levels
(r  0.33; P  .04) (Figure 1E).
Inflammatory cytokine and adipokine profiling
Higher levels of TNF- were detected in obese children
compared to nonobese (7.2 vs 5.5 pg/mL; P .01) (Figure
1F). An increase in serum leptin (1217 vs 460 pg/mL; P 
.001) and a reduction in serum adiponectin levels (912 vs
1330 pg/mL; P .001) were seen in obese children (Figure
1,GandH).PBMCsfrombothcohortswerestimulatedwith
LPS for 24 hours, and increased production of IL-1 was
demonstrated in the obese cohort (2108vs 1518pg/mL;P
.01) (Figure 1I).
miR profiling
There was a 4-fold increase in miR-33a expression (P 
.001)anda3-fold increase inmiR-33bintheobesecohortcom-
paredtothenonobese (P .017) (Figure1, JandK).Therewas
no difference in the expression of miR-107 (Figure 1L).
Discussion
Inflammation and the innate immune system play a key
role in the pathogenesis of insulin resistance, T2DM, and
atherosclerosis in adults (15). This study is an observa-
tional study of an exclusively Caucasian cohort of chil-
dren. We show that alterations in immune cell frequency,
cytokine profile, and metabolic gene regulators that char-
acterize adult T2DM and atherosclerosis are present in
obese children before the development of hyperglycemia
or overt cardiovascular disease.
Obesity is associated with a chronic low-grade inflam-
matory state, a key driver of the adverse metabolic effects
of increased adiposity. Several immune cell types, includ-
ing macrophages, lymphocytes, and neutrophils, have
been extensively described in adipose tissue of obese mice
and humans (16). Increased numbers of circulatingmono-
cytes have been described in childhood obesity (6). M1
macrophages are abundant in inflamed adipose tissue and
secrete large amounts of proinflammatory cytokines such
as IL-1 and TNF- (8). Inflammatory stimuli trigger
cleavage of the scavenger receptor CD163, yielding
sCD163, a marker of macrophage activation (8).
This study reports elevated levels of sCD163 in obese
children, reflecting increased macrophage activation with
polarization toward the M1 proinflammatory subtype. A
prospective studyof almost9000Danishadults found that
increased serum concentrations of sCD163 are associated
with up to five times the risk of development of T2DM,
even when data are adjusted for BMI, physical activity,
and lipid profile (17). Althoughwe do report a correlation
between BMI and sCD163, unlike studies in adults,
sCD163 in children does not correlate with insulin resis-
tance. This may reflect an earlier stage of the obesity in-
flammatory spectrum.Whether sCD163 could be used as
a biomarker to prioritize children for lifestyle intervention
Table 1. Characteristics of Study Subjects
Nonobese Obese P value
n 20 29
Gender, males/females (% male) 13/7 (65) 13/16 (45) ns
Pubertal status, n (%)
Prepubertal 11 (55) 9 (31) ns
Pubertal/postpubertal 9 (45) 20 (69) ns
Age, y 12.8  3.2 13.0  3.0 ns
Height, cm 147.0  18.1 158.1  15.4 .012
Weight, kg 43.0  15.5 90.0  27.5 .001
z-BMI 0.2  1.1 3.4  0.5 .001
Fasting glucose, mmol/L 4.8  0.4 5.0  0.4 ns
Fasting insulin, pmol/L 27.6  20.20 149.0  104.0 .001
HOMA-IR 0.8  0.7 4.8  3.5 .001
Cholesterol, mmol/L 3.2  0.4 3.9  0.7 .004
High-density lipoprotein, mmol/L 1.3  0.1 1.0  0.2 .001
Low-density lipoprotein, mmol/L 1.9  0.5 2.5  0.6 .007
Triglycerides, mmol/L 0.7  0.1 1.1  0.4 .001
Systolic BP, mm Hg 110  9.5 116  13.5 ns
Abbreviations: ns, not significant; HOMA-IR, homeostasis model of assessment for insulin resistance; BP, blood pressure; z-BMI, z-score for BMI.
Data are expressed as mean  SD.
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based on future risk of metabolic disease will need pro-
spective evaluation.
This study demonstrates reduced frequency of circu-
lating iNKT cells in obese children, with an inverse rela-
tionship between sCD163 concentration and iNKT cell
number. iNKT cells are a rare subset of innate T cells that
bridge innate and adaptive immunity andmay act as a link
between the immune and metabolic systems (10). Recent
work in a murine model demonstrated that mice lacking
iNKT cells had increased weight gain, insulin resistance,
and M1 macrophage polarization on a high-fat diet.
Adoptive transfer of iNKT cells led to decreased body fat
and insulin sensitivity paired with a decrease in M1 mac-
rophage frequency (10). The current study demonstrates
the same inverse relationship between increasedM1mac-
rophage polarization (sCD163) and decreased iNKT cell
frequency in obese children. This is further evidence that
the immune dysregulation seenmay be contributing to the
metabolic disturbances associated with obesity.
Elevated levels of proinflammatory serum cytokines
have previously beendescribed in childhoodobesity (6, 7).
Schipper et al (6) studied novel circulating inflammatory
mediators in children aged 6 to 16 years. They reported
increased levels of chemerin, IL-18, EGF, and TNF-R2 in
the obese group compared to the lean group (6). We have
extended this by demonstrating an altered cytokine pro-
duction fromPBMCs. StimulatedPBMCs fromobese chil-
dren produced significantly more IL-1 than those from
their lean counterparts. IL-1 is released from macro-
phages in response to activation by large multiprotein
complexes termed “inflammasomes”. IL-1 plays a key
role in pancreatic -cell toxicity, progression of inflam-
mation, and induction of insulin resistance, and thus is
considered highly pathogenic in obesity-relatedmetabolic
Figure 1. Inflammation, immune cell, and miR profiling in childhood obesity. A, Levels of sCD163 (ng/mL), a molecule released by
proinflammatory macrophages in the serum of nonobese and obese cohorts. B and C, sCD163 levels correlate with BMI but not fasting insulin. D,
Scatterplot showing the levels of circulating iNKT cells (expressed as percentage of T lymphocytes) as determined by flow cytometry; and E, their
correlation with sCD163 levels in nonobese and obese cohorts. F, Scatterplot showing the levels of the proinflammatory cytokine TNF- (pg/mL).
G, Scatterplot showing levels of leptin (pg/mL) in the serum of nonobese and obese cohorts. H, Scatterplot showing the levels of adiponectin (pg/
mL) in the serum of nonobese and obese cohorts. I, Scatterplot showing the levels of IL-1 (pg/mL) produced by LPS-stimulated PBMCs from
nonobese and obese cohorts. Cytokines and adipokines were measured in duplicate using ELISA. J–L, Levels of miR-33a (J), miR-33b (K), and miR-
107 (L) (relative expression compared to endogenous control) detected by quantitative RT-PCR in the circulating PBMCs from nonobese and obese
cohorts. *, P  .05; **, P  .01; ***, P  .001.
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disease (18). Antagonism of IL-1 is currently being tar-
geted as a possible therapeutic strategy for T2DM (19).
The fact that PBMCs from obese children produce 40%
more IL-1 than PBMCs from nonobese children is of
concern, given their current insulin resistance and likely
increased future risk of T2DM.
Upstream from cytokine protein translation, small
noncoding RNAs regulate gene expression and have been
implicated in fine-tuning many physiological and patho-
logical metabolic processes. Over 1000 sequences have
beendescribed in humans,with several of thesemiRs iden-
tified in adipocyte biology and energy metabolism (11).
MiR-33 is a key regulator in lipid homeostasis and the
initiation and progression of atherosclerosis (20). This
study demonstrates an increase in bothmiR-33a andmiR-
33b in obese children—miRs that are known to inhibit
generation of high-density lipoprotein cholesterol and re-
duce cellular fatty acid oxidation (20). MiR-107, impli-
cated in insulin resistance in adults, is similar in the obese
and nonobese cohorts. This suggests that some of the pro-
cesses underpinning insulin resistance may not yet be un-
der way at this age and highlights the importance of early
intervention even in established childhood obesity. The
identification of dysregulated miRs may ultimately pro-
vide biomarkers that support targeted interventions to
those most at risk of complications.
A limitation of this study is that the cohorts were not
matched for pubertal status or insulin resistance. Further
studieswill be required to determine the impact of both on
the clear differences we have observed between the obese
and nonobese cohorts.
In summary, childhood obesity associated with insulin
resistance impacts on the immune system at multiple lev-
els, including cytokine production, macrophage polariza-
tion, innate immune cell frequency, and regulation of gene
expression.These changes have been causally linked to the
onset of metabolic disease in adulthood and suggest the
future trajectory of obese children to the development of
T2DM and premature cardiovascular disease.
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